Joint FDA, NCI program aims to streamline cancer drug development.
D000970:Antineoplastic Agents; D033183:Interdisciplinary Communication; D009315:National Institute of Mental Health (U.S.) / Q000458:organization & administration*; D009369:Neoplasms / Q000188:drug therapy; D009937:Organizational Objectives; D016730:Program Development; D014481:United States; D014486:United States Food and Drug Administration / Q000458:organization & administration*
D000970:Antineoplastic Agents